Other Briefings
India Fast-Tracks New Drug & Clinical Trial Approvals with 2026 NDCT Amendments
India’s 2026 amendments to the New Drug and Clinical Trials (NDCT) Rules, 2019, materially improve the operating environment for pharmaceutical companies, contract manufacturers, and foreign investors by compressing approval timelines and reducing pre-licensing bottlenecks.
After 10 Months of Tariff Deadlock, US and India Find Common Ground on Trade
The White House has revised its February 2026 factsheet on the interim India-US trade framework, softening procurement language from “committed” to “intends” regarding over US$500 billion in US goods.
India Pitches Semiconductors, Clean Energy to Malaysian Capital During Modi Visit
Prime Minister Narendra Modi’s visit to Kuala Lumpur, Malaysia, signals India’s push to attract Malaysian capital into semiconductors, clean energy, digital payments, and advanced manufacturing.
US to Reduce Tariffs on Indian Exports Within Days: India’s Commerce Minister
The US is set to roll back tariffs on Indian exports from 50 percent to 18 percent within days, according to the commerce minister. The signing of a joint statement, expected between February 11 and 13, 2026, will activate the first phase of the India–US trade framework.
CDSCO Introduces Online Risk Classification Portal for Medical Device Importers and Manufacturers
India’s medical device regulatory authority, CDSCO, has rolled out a new online risk classification facility, allowing manufacturers and importers to confirm a medical device’s risk class before licensing—reducing uncertainty at a key stage of India’s regulatory process.
India’s Orange Economy: Creative Industries Outlook After Budget 2026
As of 2026, India’s orange economy is emerging as a high-growth services opportunity, spanning media, live concerts, AVGC, and creative industries, supported by policy reform.
India-US Trade Deal Cuts Tariffs, Lifts Export and Investment Outlook
India’s new trade agreement with the US reduces tariff risk, boosts exporter confidence, and signals renewed momentum for manufacturing, agriculture, and FDI-linked sectors.
India’s Union Budget 2026-27: Industrial Growth, Infrastructure Spending, Tax Reforms, and What Global Investors Need to Know
India’s Union Budget 2026–27 outlines major manufacturing incentives, infrastructure capex, tax simplification, and investor facilitation. Key takeaways for global investors.
